Home Newsfeeds Steakholder Foods Files Provisional Patent Application For Improved Fat Differentiation Process

Steakholder Foods Files Provisional Patent Application For Improved Fat Differentiation Process

The patent filing describes a novel process for achieving a higher degree of fat differentiation and significantly lowering costs for cultivated fat production

byBenzinga Newsdesk

October 6, 2022

1 minute read

The patent filing describes a novel process for achieving a higher degree of fat differentiation and significantly lowering costs for cultivated fat production

Artelo Biosciences Announces Selection Of Worldwide Clinical Trials As Clinical Research Organization To Support First-In-Human Study Of ART26.12

By Benzinga Newsdesk

January 8, 9:47 AM

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological

ARTL

Why Are Tencent And NetEase Shares Up Today? Hint: It Has To Do With Chinese Goverment Gaming Regulations

By Franca Quarneti

January 23, 4:56 PM

China's gaming regulator has removed proposed rules from its website that aimed at curbing spending and rewards in video games.

NTES

Piper Sandler Reinstates Neutral on Carter Bankshares, Announces $19 Price Target

By Benzinga Newsdesk

December 5, 9:57 AM

Piper Sandler analyst Casey Orr Whitman reinstates Carter Bankshares (NASDAQ:CARE) with a Neutral and announces $19 price target.

CARE

Teradyne Q4 EPS $0.92 Beats $0.75 Estimate, Sales $731.84M Beat $711.58M Estimate

By Benzinga Newsdesk

January 25, 6:15 PM

Teradyne (NASDAQ:TER) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.75 by 22.67 percent. This is a 32.85 percent decrease over earnings of $1.37 per share from the same

TER

Steakholder Foods Files Provisional Patent Application For Improved Fat Differentiation Process

Related Posts

Artelo Biosciences Announces Selection Of Worldwide Clinical Trials As Clinical Research Organization To Support First-In-Human Study Of ART26.12

Why Are Tencent And NetEase Shares Up Today? Hint: It Has To Do With Chinese Goverment Gaming Regulations

Piper Sandler Reinstates Neutral on Carter Bankshares, Announces $19 Price Target

Teradyne Q4 EPS $0.92 Beats $0.75 Estimate, Sales $731.84M Beat $711.58M Estimate